Tech Company Financing Transactions

Morphic Holding Funding Round

Morphic Holding closed a $80 million Series B funding round on 9/26/2018. Investors included Novo Ventures, Omega Funds and EcoR1 Capital Management.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

35 Gatehouse Dr. A2
Waltham, MA 02451
USA

Phone

(781) 996-0955

Website

www.morphictx.com

Email Address

[email protected]

Overview

Morphic Holding (Nasdaq: MORF) is engaged in the discovery and development of small molecules to block transmembrane integrin receptors, which play a role in several diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Praveen Tipirneni

        

Chief Scientific Officer

Bruce Rogers

        

VP - Bus. Development

Alexey Lugovskoy

        

VP - Finance

Robert Farrell

        

Browse more venture capital transactions:

Prev: 9/26/2018: Cybrary venture capital transaction
Next: 9/26/2018: MouSensor venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary